APA (7th ed.) Citation

J, B., GR, M., GR, S., LC, L., KD, H., DV, C., . . . PE, K. (2022). Clinical and economic evaluation of a proteomic biomarker preterm birth risk predictor: Cost-effectiveness modeling of prenatal interventions applied to predicted higher-risk pregnancies within a large and diverse cohort. Journal of medical economics, 25(1), 1255. https://doi.org/10.1080/13696998.2022.2147771

Chicago Style (17th ed.) Citation

J, Burchard, et al. "Clinical and Economic Evaluation of a Proteomic Biomarker Preterm Birth Risk Predictor: Cost-effectiveness Modeling of Prenatal Interventions Applied to Predicted Higher-risk Pregnancies Within a Large and Diverse Cohort." Journal of Medical Economics 25, no. 1 (2022): 1255. https://doi.org/10.1080/13696998.2022.2147771.

MLA (9th ed.) Citation

J, Burchard, et al. "Clinical and Economic Evaluation of a Proteomic Biomarker Preterm Birth Risk Predictor: Cost-effectiveness Modeling of Prenatal Interventions Applied to Predicted Higher-risk Pregnancies Within a Large and Diverse Cohort." Journal of Medical Economics, vol. 25, no. 1, 2022, p. 1255, https://doi.org/10.1080/13696998.2022.2147771.